May 16, 2020

Kellogg Licenses APTs Test & Learn Platform

Kelloggs
Applied Predictive Technologies
APT
consumer goo
Admin
2 min
Kellogg's is reviewing its strategic initatives
Applied Predictive Technologies (APT), the worlds largest purely cloud-based predictive analytics software company, announced today that Kellogg, a lead...

Applied Predictive Technologies (APT), the world’s largest purely cloud-based predictive analytics software company, announced today that Kellogg, a leading worldwide Consumer Packaged Goods (CPG) manufacturer of many well-known cereal, snack, and frozen food brands, has licensed APT’s Test & Learn software to test strategic initiatives across its brand portfolio.

With this agreement, Kellogg joins many other industry-leading manufacturers, including Anheuser-Busch, Johnson & Johnson, and Procter & Gamble, who use APT’s cloud-based Test & Learn™ software to evaluate initiatives in merchandising, product, pricing, and operations.

“After working with APT to generate value from several key initiatives, including modular resets and product changes, we are excited to begin an agreement to license APT’s Test & Learn software,” said Stacey Ring-Sanders, VP of Category Management at Kellogg. “APT’s software enables us to make profitable decisions with unmatched speed and accuracy across the entire organisation, providing significant competitive advantage.

“APT’s software also helps us drive value for our retail partners by clearly identifying the optimal rollout strategy for new initiatives.

“For many of our retail partners who also use APT, the software has improved lines of communication by bringing a standardised analytical platform to measure the impact of any initiative.”

 “APT is pleased to support Kellogg as they institutionalise Test & Learn to inform go-to-market decisions,” said APT President & Chief Operating Officer, Patrick O’Reilly. “Identifying the incremental impact of a program can be extremely challenging for CPG manufacturers due to the volatile retail environment.

“Test & Learn allows CPGs and their retail partners to determine the true cause-and-effect relationship between a business action and changes in key performance metrics.”

Share article

Jun 8, 2021

IMF: Variants Can Still Hurt Manufacturing Recovery

IMF
Manufacturing
COVID19
Musk
Elise Leise
3 min
The International Monetary Fund (IMF) claims that while markets are rising and manufacturing is coming back, it’ll push for global immunisation

After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022

Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery. 

Lingering Concerns Over COVID

Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high. 

Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery? 

IMF: Current Boom Could Falter

Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”. 

Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”. 

Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.

Share article